
Monitor the upcoming Anthropic IPO closely, as it offers the first direct retail access to a frontier AI lab with a projected valuation exceeding $1.8 trillion. Investors should consider NVIDIA (NVDA) as it expands beyond data centers into the consumer PC market with its new N1 and N1X chips to challenge Apple and Intel. Microsoft (MSFT) remains a high-conviction play for enterprise stability as it pivots to in-house AI models to reduce its dependency on OpenAI. In the biotech sector, look for exposure to "epigenetic reprogramming" and gene-editing firms like Verve Therapeutics, which are targeting massive longevity markets. The current U.S. regulatory environment of "voluntary review" provides a bullish tailwind for domestic AI leaders, prioritizing growth and market dominance over restrictive European-style compliance.
Anthropic has confidentially filed for an IPO with the SEC, potentially becoming the first major "frontier lab" to go public. The company is currently valued at a massive scale despite having a relatively small workforce of approximately 5,000 employees.
OpenAI continues to lead in distribution and is expanding its reach into physical infrastructure and specialized security models.
Microsoft is signaling a shift away from total reliance on OpenAI by developing its own in-house AI stack.
NVIDIA is moving beyond the data center to challenge the personal computing market.

By PHD Ventures
Tracking the future of technology and how it impacts humanity. Named by Fortune as one of the “World’s 50 Greatest Leaders,” Peter H. Diamandis, MD, is a founder, investor, advisor, and best-selling author. Join Peter on his mission to uplift humanity through technology. Follow Peter on X - https://x.com/PeterDiamandis